Public Profile

Geistlich Pharma AG

Geistlich Pharma AG, a leading name in the regenerative medicine sector, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 1851, the company has established itself as a pioneer in dental and orthopaedic biomaterials, focusing on innovative solutions for tissue regeneration. With a strong emphasis on research and development, Geistlich Pharma offers a range of unique products, including collagen-based membranes and bone substitutes, which are renowned for their quality and efficacy. The company’s commitment to scientific excellence has positioned it as a trusted partner in the healthcare industry, achieving notable milestones in clinical applications and product advancements. Geistlich Pharma AG continues to set benchmarks in regenerative medicine, enhancing patient outcomes worldwide.

DitchCarbon Score

How does Geistlich Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Geistlich Pharma AG's score of 26 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Geistlich Pharma AG's reported carbon emissions

Geistlich Pharma AG, headquartered in Switzerland (CH), currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for reducing greenhouse gas emissions across various scopes, including Scope 1 (direct emissions), Scope 2 (indirect emissions from energy), and Scope 3 (indirect emissions from the supply chain). As the industry evolves, Geistlich Pharma AG may consider establishing measurable climate commitments to align with global sustainability goals and enhance its environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Geistlich Pharma AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Geistlich Pharma AG is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Geistlich Pharma AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Keystone Dental, Inc.

US
Health and social work services (85)
Updated about 16 hours ago

Dentsply Sirona

US
Health and social work services (85)
Updated about 16 hours ago

Dentsply IH AB

SE
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 months ago
DitchCarbon Score

ACE Surgical Supply Co., Inc.

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Antibe Therapeutics Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Nobel Biocare Holding AG

CH
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers